Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial
| Image |  |
|---|---|
| Description | scientific article published on 07 August 2018 |
| Author/s |
author: Georgina V. Long Antoni Ribas Matteo Carlino Christian U Blank Dirk Schadendorf |
| Publication date | August 7, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |